Investigator-initiated Research (IIR) and Collaborative Research Grants
Investigator-initiated Research (IIR) and Collaborative Research Grants support external investigators’ studies relevant to Neurocrine’s clinical programs to advance scientific knowledge and improve patient care.
Funder: Neurocrine Biosciences
Funding Amounts: Research funding, Neurocrine product, or both
Summary: Supports externally sponsored research relevant to Neurocrine’s clinical programs to advance scientific knowledge and improve patient care and outcomes.
Key Information: Investigators retain responsibility for study design, implementation, conduct, and institutional and regulatory compliance.
Description
Neurocrine Biosciences’ Investigator-initiated Research (IIR) and Collaborative Research Grants program connects the company with external investigators conducting their own trials. It supports studies sponsored by outside investigators or institutions that advance medical and scientific knowledge and are of interest to Neurocrine. Support may include research funding, Neurocrine product, or both.
Studies can generate information about Neurocrine products and broader medical and scientific knowledge that informs improvements in clinical care, development of new treatments, and better healthcare delivery. Published research interests focus on valbenazine in tardive dyskinesia and Huntington’s disease with chorea, and crinecerfont in congenital adrenal hyperplasia. These interests span treatment benefits, biological effects, screening and diagnosis, real-world outcomes, functional impact, care transitions, and unmet clinical needs.
